Canada markets closed

Celyad Oncology SA (CYAD.BR)

Brussels - Brussels Delayed Price. Currency in EUR
Add to watchlist
0.3190+0.0185 (+6.16%)
At close: 05:35PM CEST
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
12,445
30,018
17,234
39,338
Other Short Term Investments
0
0
0
0
Total Cash
12,445
30,018
17,234
39,338
Net Receivables
909
203
165
156
Other Current Assets
-
-
1
-
Total Current Assets
14,825
34,292
19,705
42,836
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,453
11,092
10,846
11,408
Accumulated Depreciation
-1,144
-7,844
-6,727
-6,347
Net property, plant and equipment
309
3,248
4,119
5,061
Goodwill
0
883
883
883
Intangible Assets
864
35,285
35,288
35,316
Other long-term assets
-
-
-1
-
Total non-current assets
4,891
45,651
46,379
47,000
Total Assets
19,716
79,943
66,084
89,836
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
-
-
37
192
Accounts Payable
4,752
6,611
4,736
6,969
Accrued liabilities
1,294
1,798
1,653
1,750
Deferred revenues
1,326
1,458
2,209
1,012
Other Current Liabilities
710
2,338
1,316
350
Total Current Liabilities
10,426
13,827
11,834
11,922
Non-current liabilities
Long Term Debt
-
-
-
37
Deferred revenues
4,584
5,851
4,220
4,139
Other long-term liabilities
258
164
371
-
Total non-current liabilities
4,973
22,477
23,256
32,295
Total Liabilities
15,399
36,304
35,090
44,217
Stockholders' Equity
Common Stock
78,585
78,585
48,513
48,513
Retained Earnings
-349,947
-308,997
-283,039
-74,424
Accumulated other comprehensive income
269,362
267,734
222,171
28,181
Total stockholders' equity
4,317
43,639
30,994
45,619
Total liabilities and stockholders' equity
19,716
79,943
66,084
89,836